Related references
Note: Only part of the references are listed.Analytical strategies for phosphoproteomics
Tine E. Thingholm et al.
PROTEOMICS (2009)
Quantitative phosphoproteome analysis of a mouse liver cell line reveals specificity of phosphatase inhibitors
Cuiping Pan et al.
PROTEOMICS (2008)
Derailed endocytosis: an emerging feature of cancer
Yaron Mosesson et al.
NATURE REVIEWS CANCER (2008)
Structural basis for activation of the autoinhibitory C-terminal kinase domain of p90 RSK2
Margarita Malakhova et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Phosphoinositol phosphatase SHIP2 promotes cancer development and metastasis coupled with alterations in EGF receptor turnover
Nagendra K. Prasad et al.
CARCINOGENESIS (2008)
Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer
Klarisa Rikova et al.
CELL (2007)
The Tom1L1-clathrin heavy chain complex regulates membrane partitioning of the tyrosine kinase Src required for mitogenic and transforming activities
Guillaume Collin et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
CS1 (CRACC, CD319) induces proliferation and autocrine cytokine expression on human B lymphocytes
Jae Kyung Lee et al.
JOURNAL OF IMMUNOLOGY (2007)
The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy
Yang Yang et al.
BLOOD (2007)
FGFR3 activates RSK2 to mediate hematopoietic transformation through tyrosine phosphorylation of RSK2 and activation of the MEK/ERK pathway
Sumin Kang et al.
CANCER CELL (2007)
A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration
Menachem Katz et al.
NATURE CELL BIOLOGY (2007)
Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma
Paul H. Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Phosphoproteomics identified Endofin, DCBLD2, and KIAA0582 as novel tyrosine phosphorylation targets of EGF signaling and Iressa in human cancer cells
Yunhao Chen et al.
PROTEOMICS (2007)
Epidermal growth factor receptor fate is controlled by Hrs tyrosine phosphorylation sites that regulate Hrs degradation
Kathryn A. Stern et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Quantitation of multisite EGF receptor phosphorylation using mass spectrometry and a novel normalization approach
Elisabetta Boeri Erba et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Global, in vivo, and site-specific phosphorylation dynamics in signaling networks
Jesper V. Olsen et al.
CELL (2006)
Rab11a differentially modulates epidermal growth factor-induced proliferation and motility in immortal breast cells
Diane Palmieri et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Differential analysis of membrane proteins in mouse fore- and hindbrain using a label-free approach
Thierry Le Bihan et al.
JOURNAL OF PROTEOME RESEARCH (2006)
CHIR-258 is efficacious in a newly developed fibroblast growth factor receptor 3-expressing orthotopic multiple myeloma model in mice
Xiahua Xin et al.
CLINICAL CANCER RESEARCH (2006)
Phosphoproteomic approaches to elucidate cellular signaling networks
Katrin Schmezle et al.
CURRENT OPINION IN BIOTECHNOLOGY (2006)
Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b
I Bernard-Pierrot et al.
CARCINOGENESIS (2006)
Autophosphorylation of FGFR1 kinase is mediated by a sequential and precisely ordered reaction
CM Furdui et al.
MOLECULAR CELL (2006)
The adaptor protein Tom1L1 is a negative regulator of Src mitogenic signaling induced by growth factors
M Franco et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
A quantitative protein interaction network for the ErbB receptors using protein microarrays
RB Jones et al.
NATURE (2006)
Met/hepatocyte growth factor receptor ubiquitination suppresses transformation and is required for Hrs phosphorylation
JV Abella et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules
Y Zhang et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Pituitary tumor transforming gene binding factor: A novel transforming gene in thyroid tumorigenesis
AL Stratford et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Constitutively activated FGFR3 mutants signal through PLCγ-dependent and -independent pathways for hematopoietic transformation
J Chen et al.
BLOOD (2005)
SH2-containing 5′-inositol phosphatase, SHIP2, regulates cytoskeleton organization and ligand-dependent downregulation of the epidermal growth factor receptor
NK Prasad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cellular signaling by fibroblast growth factor receptors
VP Eswarakumar et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Interactions of Tom1L1 with the multivesicular body sorting machinery
R Puertollano
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Phosphotyrosine interactome of the ErbB-receptor kinase family
Waltraud X. Schulze et al.
MOLECULAR SYSTEMS BIOLOGY (2005)
Immunoaffinity profiling of tyrosine phosphorylation in cancer cells
J Rush et al.
NATURE BIOTECHNOLOGY (2005)
Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074
EK Grand et al.
LEUKEMIA (2004)
Preclinical studies of fibroblast growth factor receptor 3 as a therapeutic target in multiple myeloma
JL Paterson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors
CS Mitsiades et al.
CANCER CELL (2004)
Specificity in signal transduction: From phosphotyrosine-SH2 domain interactions to complex cellular systems
T Pawson
CELL (2004)
Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics
B Blagoev et al.
NATURE BIOTECHNOLOGY (2004)
Advances in biology of multiple myeloma: clinical applications
T Hideshima et al.
BLOOD (2004)
Single cell profiling of potentiated phospho-protein networks in cancer cells
JM Irish et al.
CELL (2004)
Inhibition of fibroblast growth factor receptor 3 induces differentiation and apoptosis in t(4;14) myeloma
S Trudel et al.
BLOOD (2004)
Signaling initiated by overexpression of the fibroblast growth factor receptor-1 investigated by mass spectrometry
AM Hinsby et al.
MOLECULAR & CELLULAR PROTEOMICS (2003)
Novel mRNA molecules are induced in hypertrophied ventricles of carnitine-deficient mice and belong to a family of up-regulated gene in cells overexpressing c-erbB-2
S Fukumaru et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2002)
Srcasm: a novel Src activating and signaling molecule
JT Seykora et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Tyrosine phosphorylation mapping of the epidermal growth factor receptor signaling pathway
H Steen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations
D Ronchetti et al.
ONCOGENE (2001)
Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation
KC Hart et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4
KC Hart et al.
ONCOGENE (2000)
Share Paper
